Alzheimer Disease Clinical Trial
Official title:
Coordinating Center for Enhancing Alzheimer Disease and Related Disorder Caregiving
Established in 1995, Resources for Enhancing Alzheimer's Caregiver Health (REACH) is a unique, multi-site research program sponsored by the National Institute on Aging (NIA) and the National Institute on Nursing Research (NINR). The primary purpose of REACH is to carry out social and behavioral research on interventions designed to enhance family caregiving for Alzheimer's disease and related disorders. Specifically, REACH has two goals: to test the effectiveness of multiple different interventions and to evaluate the pooled effect of REACH interventions overall. REACH grew out of a National Institute of Health (NIH) initiative that acknowledged the well-documented burdens associated with family caregiving as well as the existence of promising family caregiver interventions reported in the literature.
Six sites (Boston, Birmingham, Memphis, Miami, Palo Alto, and Philadelphia) developed and
evaluated a variety of multi-component interventions for family caregivers of persons with
Alzheimer’s Disease (AD) at the mild or moderate level of impairment. The multi-component
interventions implemented across the six sites included: 1) Individual Information and
Support strategies, 2) Group Support and Family Systems therapy, 3) Psychoeducational and
Skill-based Training approaches, 4) Home-based Environmental interventions,, and 5) Enhanced
Technology Support Systems. Although the interventions were derived from diverse theoretical
models, they are all consistent with basic health-stress models in which the goal is to
change the nature of specific stressors (e.g. problem behavior of the care recipient), their
appraisal, and/or the caregivers response to the stressors. All of the REACH interventions
were guided by detailed treatment manuals and certification procedures that assured that the
interventions were delivered consistently over time at each site. Careful attention was also
paid to the issue of treatment integrity. Different strategies were used at each site to
induce and assess all three fundamental aspects of treatment integrity: delivery, receipt,
and enactment (Burgio, et al., 2001). In addition, because the caregiving experience in race
and ethnic minority families is particularly neglected in the field, there was a strong
emphasis placed on the inclusion of African American and Hispanic caregivers. Thus,
assessments as well as interventions were tailored at each site to meet the needs of
culturally diverse racial/ethnic majority and minority populations.
All of the REACH sites shared several common goals, including: 1) designing theory-driven
caregiving interventions to test hypotheses about intervention processes and their effect on
family caregivers, 2) specifying intervention components that help us understand the
pathways through which interventions produce desired outcomes, 3) developing a standardized
outcome protocol to assess the impact of different strategies on caregivers and their care
recipients within each site and across sites, and 4) creating a common database that would
facilitate pooling data across sites. In addition, standard selection criteria were adopted
by REACH.
Although REACH has some of the features of a traditional multi-site randomized controlled
clinical trial (e.g., random assignment of participants to treatment and control conditions,
common database and outcome measures, and identical measurement intervals across sites), it
differs on one key dimension—the interventions varied across sites. REACH was designed to
examine the feasibility and outcomes of multiple different intervention approaches, rather
than to provide definitive information on the efficacy of one specific intervention strategy
for enhancing caregiver outcomes. The strength of this approach is that it efficiently
yields information about the effectiveness of different approaches to AD caregiving as well
as the combined effects of active treatment versus controls, as reported in the planned
meta-analysis.
REACH successfully randomized 1222 caregiver/care recipient dyads representing both majority
and minority populations to 15 different conditions.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
| Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
| Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
| Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
| Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
| Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
| Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
| Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
| Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
| Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
| Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
| Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
| Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
| Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
| Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
| Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
| Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
| Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
| Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |